MARATTO

article · BMC Primary Care

Validation of the patient-doctor relationship questionnaire: a cross-sectional study among exit patients in Ghana

Abstract

BACKGROUND: The patient-doctor relationship is an essential component of patient-centered care. But there are limited tools available for assessment, especially in the low- and middle-income countries, including Ghana. This study aimed to validate the Patient-Doctor Relationship Questionnaire-9 (PDRQ-9) in Ghana. METHODS: A cross-sectional validation study was conducted among 366 exit patients aged ≥ 18 in October 2023 at the Family Medicine Directorate Outpatient Clinic of the Komfo Anokye Teaching Hospital in Ghana. After taking the PDRQ-9 through adoption, face validation, and field testing, factor analysis and internal consistency testing were done. RESULTS: At a significant Bartlett's test of sphericity, p < 0.001, the Kaiser-Meyer-Olkin value was 0.94. Principal Component Analysis yielded only one component factor, which explained 81% of the variance. One eigenvalue exceeded 1.0. The bend of the scree plot was at the second factor, and one factor remained above the random values in parallel analysis. The factor loadings ranged between 0.4 and 0.97. The Cronbach's alpha for the PDRQ-9 Ghana version was 0.96. CONCLUSION: The PDRQ-9 Ghana version is a valid and reliable unidimensional scale that can adequately measure patient satisfaction with their relationship with primary care physicians in the study population. It can serve as a tool for quality improvement.

Research topics

  • Patient Satisfaction in Healthcare
  • Patient-Provider Communication in Healthcare
  • Healthcare Systems and Technology

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1186/s12875-026-03363-w

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.